Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia

Eitemau Tebyg

• Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia
  gan: Cherif, Honar, et al.
  Cyhoeddwyd: (2014)
• Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler’s Disease, Uppsala University Hospital
  gan: Karlsson, Torbjörn, et al.
  Cyhoeddwyd: (2018)
• Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency
  gan: Finnamore, Helen, et al.
  Cyhoeddwyd: (2013)
• Cobalamin and iron deficiency still presents a challenge in hereditary hemorrhagic telangiectasia
  gan: Marie Carolin Schleupner, et al.
  Cyhoeddwyd: (2025-08-01)
• The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial
  gan: Keller, Peter, et al.
  Cyhoeddwyd: (2020)